8-K: BioSig Technologies Commences Trading on OTCQB After Nasdaq Delisting

BioSig Technologies began trading on the OTCQB market on July 23, 2024, following its delisting from the Nasdaq.

Summary

• BioSig Technologies, Inc. started trading its common stock on the OTCQB market on July 23, 2024.
• This move follows the suspension of the company's securities trading on the Nasdaq, which became effective on June 12, 2024.
• The company's stock was eligible to trade on the OTC Markets Pink Current Information after the Nasdaq suspension.
• BioSig Technologies has appealed the Nasdaq delisting decision and is awaiting a response from the Nasdaq Listing and Hearing Review Council.

Sentiment

Score: 3

Explanation: The delisting from Nasdaq and move to OTCQB is a significant negative event, indicating potential financial or compliance issues. The appeal is a small positive, but the overall sentiment is negative.

Positives

• The company has successfully transitioned to trading on the OTCQB market, ensuring continued trading of its stock.

Negatives

• The company's stock was delisted from the Nasdaq, a major exchange, which could negatively impact investor confidence.
• The company is now trading on the OTCQB market, which is generally considered less prestigious than the Nasdaq.

Risks

• The appeal to the Nasdaq Listing and Hearing Review Council may not be successful, and the company may remain delisted.
• Trading on the OTCQB market may result in lower trading volumes and potentially lower valuations.

Future Outlook

The company is awaiting a decision on its appeal to the Nasdaq Listing and Hearing Review Council.

Management Comments

• Anthony Amato, Chief Executive Officer, signed the report on behalf of the company.

Industry Context

Delisting from a major exchange like Nasdaq and moving to the OTC market is generally seen as a negative event for a company, often indicating financial or compliance issues. This move places BioSig Technologies among companies with lower market capitalization and potentially higher risk profiles.

Comparison to Industry Standards

• Companies that are delisted from major exchanges like Nasdaq often face challenges in maintaining investor confidence and accessing capital.
• Trading on the OTCQB market is common for companies that do not meet the listing requirements of major exchanges, such as Nasdaq or NYSE.
• Compared to companies listed on Nasdaq, BioSig Technologies may experience lower trading volumes and potentially lower valuations on the OTCQB.

Stakeholder Impact

• Shareholders may experience a decrease in the value of their investment due to the delisting and move to the OTCQB market.
• The company's ability to raise capital may be negatively impacted by the delisting.

Next Steps

• The company is awaiting a decision on its appeal to the Nasdaq Listing and Hearing Review Council.

Key Dates

Keywords

OTCQB, Nasdaq, delisting, trading, appeal, BioSig Technologies, BSGM, OTC Markets